Matinas BioPharma Holdings, Inc. (MTNB) Form 8-K — Jun 26, 2026
$MTNBForm 8-KItems 3.01, 8.01, 9.01Filed Jun 26, 2026, 5:15 PM ET0001493152-26-030342Original filing
Matinas BioPharma Holdings, Inc. received a notice from NYSE American indicating it is not in compliance with continued listing standards regarding stockholders' equity. As of March 31, 2026, the company reported equity of $3.02 million, which is below the $4.0 million threshold required for companies that have reported losses in recent fiscal years. The NYSE American accepted the company's plan to regain compliance, granting a cure period through October 2, 2027.
Key figures
- Stockholders Equity
- 3022000
- Stockholders Equity Prior
- 4830000
- Plan Period Deadline
- 2027-10-02
- Compliance Threshold Low
- 4000000
- Compliance Threshold High
- 6000000
Price after filing
1 day: 0.0%7 days: +1.7%30 days: -60.0%
Close on the filing date to close N calendar days later (from $0.62). Historical, not a forecast.
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.